Polymorphism in two merozoite surface proteins of Plasmodium falciparum isolates from Gabon -: art. no. 12

被引:66
|
作者
Aubouy, A
Migot-Nabias, F
Deloron, P
机构
[1] IRD, Mother & Child Hlth Trop UR010, Fac Pharm, Parasitol Lab, F-75006 Paris, France
[2] Ctr Int Rech Med Franceville, Unite Parasitol Med, Franceville, Gabon
[3] IRD, Mother & Child Hlth Trop UR010, Dakar, Senegal
关键词
D O I
10.1186/1475-2875-2-12
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Plasmodium falciparum antigenic diversity and polymorphism confuses the issue of antimalarial vaccine development. Merozoite surface protein (MSP)-1 and -2 are two highly polymorphic vaccine candidates. Characterisation of their precise polymorphism in endemic regions may facilitate the design of an effective vaccine. Methods: Isolates obtained in 52 Gabonese children presenting with uncomplicated malaria were genotyped by nested-PCR of msp-1 block 2, and msp-2 block 3, to analyze both parasite population polymorphism and clone fluctuations. Results: Twenty-five and 19 different alleles were respectively obtained for msp-1 and msp-2 loci, the RO33 family of msp-1 being poorly polymorphic. Four cases of non-random distribution of alleles were reported of the FC27, and/or 3D7 families of msp-2. All but two isolates were composed of more than one genotype, and the multiplicity of infection (MOI) was 4.0. Neither parasite density nor age was related to MOI. Clone fluctuations were studied for ten subjects who were sampled again at reappearance of parasites in blood. Disappearance and reappearance of alleles were observed following treatment, suggesting difficulties in assessing polymorphism and in distinguishing reinfection from recrudescence. Conclusion: P. falciparum polymorphism is extensive in Southeast Gabon, and most of infections are composed of multiple clones. The fluctuation of clones contributes to parasite diversity.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Decreasing chloroquine resistance in Plasmodium falciparum isolates from Gabon
    Brandts, CH
    Wernsdorfer, WH
    Kremsner, PG
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2000, 94 (05) : 554 - 556
  • [22] Genetic relatedness of Plasmodium falciparum isolates and the origin of allelic diversity at the merozoite surface protein-1 (MSP-1) locus in Brazil and Vietnam -: art. no. 24
    Hoffmann, EHE
    Ribolla, PEM
    Ferreira, MU
    MALARIA JOURNAL, 2003, 2 (1)
  • [23] Sympatric Plasmodium falciparum isolates from Venezuela have structured var gene repertoires -: art. no. 7
    Tami, A
    Ord, R
    Targett, GAT
    Sutherland, CJ
    MALARIA JOURNAL, 2003, 2 (1)
  • [24] Genetic polymorphism of merozoite surface proteins 1 and 2 of Plasmodium falciparum in the China–Myanmar border region
    Cang-Lin Zhang
    Hong-Ning Zhou
    Quan Liu
    Ya-Ming Yang
    Malaria Journal, 18
  • [25] Antigenicity of recombinant proteins derived from Plasmodium falciparum merozoite surface protein 1
    Cavanagh, DR
    McBride, JS
    MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1997, 85 (02) : 197 - 211
  • [26] Exposure of the Plasmodium falciparum clonally variant STEVOR proteins on the merozoite surface
    Ayman Khattab
    Seppo Meri
    Malaria Journal, 10
  • [27] Exposure of the Plasmodium falciparum clonally variant STEVOR proteins on the merozoite surface
    Khattab, Ayman
    Meri, Seppo
    MALARIA JOURNAL, 2011, 10
  • [28] Genetic polymorphism of merozoite surface protein 1 and merozoite surface protein 2 in the Vietnam Plasmodium falciparum population
    Vo, Tuan Cuong
    Le, Huong Giang
    Kang, Jung-Mi
    Trinh, Nguyen Thi Minh
    Quang, Huynh Hong
    Na, Byoung-Kuk
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [29] Identification of the Plasmodium chabaudi homologue of merozoite surface proteins 4 and 5 of Plasmodium falciparum
    Black, CG
    Wang, L
    Hibbs, AR
    Werner, E
    Coppel, RL
    INFECTION AND IMMUNITY, 1999, 67 (05) : 2075 - 2081
  • [30] Malaria vaccine development based on merozoite surface proteins of Plasmodium falciparum
    Chauhan, Virander S.
    Yazdani, Syed Shams
    Gaur, Deepak
    HUMAN VACCINES, 2010, 6 (09): : 757 - 762